Boxer dies at 25 after battling with doctors for months over diagnosis
British boxer Georgia O'Connor fought to the very end, ultimately losing her battle with a 'rare and aggressive' form of cancer that she said doctors ignored for months.
She was 25 years old.
O'Connor, a medal-winning boxer from Durham, England, shared her diagnosis earlier this year while tearing into the English medical system (NHS) and the doctors who overlooked her concerns.
In an Instagram post, she shared that she had been diagnosed with cancer after weeks of debilitating pain, and claimed her concerns went ignored by doctors for four months.
'For 17 weeks since the start of October, I've been in constant pain, going back and forth between Durham and Newcastle RVI A&E knowing deep down something was seriously wrong,' O'Connor wrote on Jan. 31. 'I said from the start I felt it was cancer. I KNEW the risks. I have colitis and PSC, two diseases that dramatically increase the chances of getting it. I KNOW how high my risk is and they do too. They always did.
'But not one doctor f***ing listened to me. Not one doctor took me seriously. Not one doctor did the scans or blood tests I begged for whilst crying on the floor in agony. Instead, they dismissed me. They gaslit me, told me it was nothing, made me feel like I was overreacting. They refused to scan me. They refused to investigate. They REFUSED to listen. One even told me that it's 'all in my head.' And now? Now the cancer has spread.'
'And if that wasn't enough, throughout this whole time there's been BLOOD CLOTS all over my lungs. That ALONE could have killed me instantly.
'They could have done something before it got to this stage. But they didn't. Because this is the state of the NHS — a broken system that fails young people like me over and over again. A system that makes people suffer, that sends them home in agony, that lets cancer spread whilst the thick, stupid, mindless 'doctors' shrug their shoulders.'
In the post, she vowed to win her battle with cancer before firing more shots at those who let her down.
'F*** the doctors who failed me,' she wrote. 'F*** the system that let this happen.'
Manny Pacquiao returning to the ring after losing Philippines senatorial race
Jake Paul engaged to Olympic speed skater Jutta Leerdam
O'Connor's death comes less than two weeks after she had married her partner, Adriano.
The fighter had shared a snap from their special day, showing off their wedding rings.
''09.05.2025. The day I married the love of my life,' O'Connor captioned the Instagram photo, which would be her final post on the social media platform.
In past Instagram posts, she praised Adriano for his love and support throughout her battle with cancer.
'From the moment I was diagnosed with cancer, Adriano didn't hesitate. He quit his job without a second thought and made it his mission to fight this battle alongside me. Not just by my side, but leading the charge, doing everything in his power to save me,' she wrote on Feb. 3.
'Adriano, you are my superhero. My warrior, my protector, my soulmate. I have no words strong enough to explain what you mean to me; how much I love you, how much I thank you, how much I need you. You are my safe place. My home. I could search the world a thousand times over and never find another man like you.
'Everything we've been through, we go through together. Every fight, every battle, every victory. We take it all, hand in hand. And we will win. My real-life prince. My reason. My forever.'
During her amateur in-ring career, O'Connor won a gold medal at the Commonwealth Youth Games in 2017 as well as a silver at the 2017 World Youth Championships and a bronze at the tournament in 2018.
She turned pro in 2021 and went undefeated in three fights, with her final bout coming in October 2022.
Check out our sports section for the latest news and analysis.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
MAHA, social media further complicating parenthood
(NewsNation) — New parents have always sought advice about whether to sleep train or use formula, but the 'Make America Healthy Again' movement has raised even more questions. Initiatives backed by Robert F. Kennedy Jr. have filled social media feeds with polarizing topics, including questions about raw milk, unmedicated childbirth, ultraprocessed foods and vaccinations. A national poll by C.S. Mott Children's Hospital found four out of five parents with young children — from newborn to 4 years old — use social media to discuss their concerns about a range of parenting topics. 'Agroterrorism' fungus could harm US crops, livestock: Scientist Holistic pediatrician Dr. Ana Maria Temple told NewsNation that parents can honor their own values and make sound choices — if they're able to filter out the filler they find online. Rather than following thousands of Facebook, Instagram and TikTok pages and driving 'yourself insane,' Temple recommends going 'back to finding a provider with clinical expertise that can sit and work with you.' But the divisiveness on these topics goes beyond social media — it's happening on the soccer field over post-game snacks, at kids' parties over the birthday treats served and even at schools over the cleaning products used in the classroom. Doctor: Texas junk food bill a step in the right direction Temple said to keep an open mind and avoid self-criticism when absorbing all of these different suggestions and views, both online and in person. One of the MAHA movement's most prominent thought leaders, Moms Across America founder Zen Honeycutt, suggested looking for tried-and-true options from other parents. 'Our moms have tried dozens of different ways to recover our children from their health issues, and they're sharing the ones that work the best,' Honeycutt said. 'And doesn't mean that it'll work for your child, but it's something that our mothers have tried.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Forbes
40 minutes ago
- Forbes
USA Gymnastics President Li Li Leung To Step Down After Guiding Post-Nassar Reform
MINNEAPOLIS, MINNESOTA - JUNE 30: President and CEO of USA Gymnastics Li Li Leung (C-R) poses with ... More (L-R) Hezly Rivera, Joscelyn Roberson, Suni Lee, Simone Biles, Jade Carey, Jordan Chiles and Leanne Wong after they were selected for the 2024 U.S. Olympic Women's Gymnastics Team on Day Four of the 2024 U.S. Olympic Team Gymnastics Trials at Target Center on June 30, 2024 in Minneapolis, Minnesota. (Photo by) USA Gymnastics announced Thursday that President and CEO Li Li Leung will step down at the end of the year. This will mark the end of her nearly six-year tenure at the helm, during which Leung guided the organization after the Larry Nassar scandal. Hired in March 2019, the organization credits Leung's leadership for catalyzing a 'historic turnaround" and 'cultural transformation' within the sport. Leung helped the organization rebound from the blows dealt by the Nassar sexual abuse scandal, helping place athlete wellbeing and safety at the forefront. In December 2020, USA Gymnastics established its Athlete Bill of Rights, considered one of the 'first of its kind in sport,' demonstrating a commitment to 'a culture of athlete support and safety driving organizational decision-making." Leung's organization also introduced mental health visits to the National Team program Under the addition, USA Gymnastics now covers costs for regular visits to mental health providers for National Team athletes and coaches. Leung issued the following statement: 'The opportunity to lead USA Gymnastics has been the honor and privilege of a lifetime. Thanks to the dedication of the entire gymnastics community, we are now in an incredible position as we turn our attention to the L.A. Olympic Games. The last several months have been a time of great reflection, and I know that now is the right time to pass the torch to the next leader, with the sport and organization thriving. I wanted to ensure the board has the opportunity to conduct a thorough search and also give my successor a long runway into the 2028 Olympic Games. I'm going to take some time to reset before determining what is next, and I look forward to USA Gymnastics accomplishing great things in 2025 and beyond.' During her tenure, USA Gymnastics surged to success on the medal podium, most notably with 11 medals at the 2024 Olympic Games. In addition to her role with USA Gymnastics, Leung was the recipient of multiple honors in sport. In 2020, Leung was voted vice chair of the NGB Council of the U.S. Olympic sport governing bodies, and was elected to the Executive Committee of the International Gymnastics Federation (FIG) in 2021. Leung was named a Sports Business Journal 'Power Player' in 2020 and an SBJ Gamechanger in 2024. In 2023, she was recognized on the 2023 A100 list as one of the country's most impactful Asian Americans. She would later be named a 2025 WISE Woman of the Year. Chair of the USAG board of directors, Kathryn Carson, attested to the impact of Leung's leadership. 'Li Li was the right leader at the right time for USA Gymnastics and accomplished in six years what many thought was not possible," Carson said. 'Her deep passion for gymnastics and extraordinary dedication to leading transformation has positioned USA Gymnastics to move boldly toward LA28. With this strong foundation, we are confident we will identify a leader to build on Li Li's legacy.' With a home Olympic Games on the horizon in 2028, USA Gymnastics now commits to securing a replacement in the organization's pivotal quadrennium. The organization 'has engaged CAA Executive Search to lead the search for Leung's successor,' and intends to identify a new president and CEO prior to Leung's departure at 2025's close.
Yahoo
43 minutes ago
- Yahoo
Medical Crowdfunding Market is Poised to Surpass US$ 13.55 Billion by 2033
Medical crowd funding market is expanding worldwide, propelled by digital payments, disease-specific platforms, regulatory transparency, and Gen-Z micro-donations, enabling quicker cross-border campaigns and verifiable outcomes while fostering ethical AI-driven donor confidence and sustainability. Chicago, June 05, 2025 (GLOBE NEWSWIRE) -- The global medical crowdfunding market was valued at US$ 3.47 billion in 2024 and is projected to reach US$ 13.55 billion by 2033, growing at a CAGR of 16.32% during the forecast period 2025–2033. As digital infrastructure matures, the medical crowd funding market is rapidly shifting from rudimentary appeal pages to sophisticated, mobile-first ecosystems. In 2024, leading platforms collectively processed more than 1.9 million patient campaigns, a jump of 420,000 cases compared with 2022. Seamless account creation through biometric log-in, embedded electronic health record connectors, and real-time compliance checks allow organizers to build a verifiable case narrative in under six minutes on average. This reduced friction has noticeably shortened the time between campaign launch and first donation to less than three hours, evidence that user-interface optimization directly influences velocity. Crucially, artificial intelligence now curates comparable cases, suggesting realistic funding targets and flagging potential compliance gaps. Download Sample Pages: Equally transformative is the convergence of social media livestreaming and one-click micro-donations, which amplifies reach without increasing marketing spend. The medical crowd funding market benefits from Instagram's direct-donate sticker that rolled out globally in February 2024, unlocking exposure to nearly 260 million health-focused followers in one quarter. X's redesigned Spaces feature has also become a real-time forum where transplant candidates answer donor queries, converting listening sessions into contribution spikes reaching up to 2,500 transactions per hour. These channel integrations, combined with predictive analytics that surface ideal posting windows, are raising baseline visibility for small campaigns—a clear sign that the medical crowd funding market is becoming deeply interwoven with everyday digital behavior. Key Findings in Medical Crowdfunding Market Market Forecast (2033) US$ 13.55 billion CAGR 16.32% Largest Region (2024) North America (35%) By Crowdfunding Type Donation-based (50%) By Indication Cancer Treatments (25%) By Application Medical Treatments (55%) By End User Individuals (59%) Top Drivers Rising healthcare costs pushing patients toward alternative funding solutions daily Insurance coverage gaps forcing families to seek community financial support Social media amplification enabling campaigns to reach broader donor networks Top Trends AI-powered campaign optimization tools increasing donation success rates significantly Corporate matching programs expanding employee contributions to medical fundraising campaigns Blockchain verification systems enhancing donor trust through transparent medical documentation Top Challenges Regulatory compliance requirements increasing platform operational costs and campaign verification Donor fatigue emerging from oversaturation of medical fundraising campaign requests Geographic disparities creating unequal funding access between urban rural communities Platform Evolution Reshaping Patient Financing Across Diverse Therapeutic Categories Worldwide Platform design is no longer generic; instead, campaign templates now mirror specific therapeutic journeys. Oncology fundraisers can auto-populate cost checklists from NCCN guidelines, whereas rare-disease organizers pull lab-encoded invoices directly from Genomic Passport repositories. This specialization within the medical crowd funding market reduces narrative fatigue and reassures donors that requested amounts align with clinically validated pathways. In 2023, GoFundMe created a dedicated kidney-transplant hub that attracted 38,000 searches during launch weekend alone, demonstrating pent-up demand for category-focused navigation. Similar hubs emerged on Ketto for neonatal surgeries and on Leetchi for maternal care, encouraging peer benchmarking and anchoring expectations about procedure timelines while boosting campaign trust at critical stages. Equally important, machine-readable taxonomies let researchers mine anonymized outcome data, creating feedback loops that improve future campaign accuracy. For instance, BloodCancerUK extracted 4,600 myeloma requests, revealing that accommodation and travel consume one-third of overall bills, a finding now integrated into default budgeting suggestions. Such insights demonstrate how the medical crowd funding market is morphing into an evidence-rich ecosystem rather than a static donation jar. Therapeutic segmentation also supports pharmaceutical assistance programs: Novartis piloted an integration allowing heart-failure patients to share co-pay vouchers directly in campaign widgets, cutting offline paperwork entirely. As these domain-specific features proliferate, donors can grasp why a stem-cell transplant differs financially from a CAR-T infusion, strengthening empathy. Regulatory Environments Shifting Responsibility Toward Greater Transparency And Donor Protection The regulatory lens on the medical crowd funding market sharpened considerably in 2024 when Australia's Therapeutic Goods Administration began auditing campaigns that mention off-label stem-cell procedures. Similar scrutiny followed in Canada, where the Competition Bureau compelled platforms to display fulfillment disclosures prominently. These moves are less about suppression and more about clarifying informed consent for donors who may conflate compassionate use with proven therapy. In the United States, bipartisan draft legislation named the HELP Donations Act now proposes mandatory escrow of funds until hospitals confirm appointment dates, a provision that could reduce diversion risk. Proactive platforms have already introduced voluntary vetting to stay ahead of statutory frameworks worldwide compliance expectations. Beyond government edicts, non-profit watchdogs are establishing standards that resonate across borders. 2024 guidance now requires a dynamic ledger disclosing real-time expenditure categories broken down by pharmacy fees, rehabilitation and administrative overhead. This ledger syncs through open APIs, allowing investigative journalists to cross-reference financial trails with hospital billing codes. The ensuing public visibility is nudging the medical crowd funding market toward the kind of auditable architecture long expected of public charities. Importantly, the change also reassures large corporate donors; Salesforce, for example, routed company-matched employee gifts only to campaigns equipped with verifiable disbursement dashboards. Such selective backing pressures lagging platforms to upgrade faster, ensuring uniform donor safeguards across ecosystems. Payment Integration And FinTech Partnerships Enabling Frictionless Cross-Border Donation Flows Financial technology collaborations are dismantling the currency barriers that historically throttled campaign visibility. Wise's 2024 plug-in lets organizers in Lagos receive donations in naira while donors in Berlin pay in euros, with conversion completed at mid-market rates in under three seconds. This capability pushed average cross-border gift size to 62 euros in Q1, according to platform dashboards. Within the medical crowd funding market, Stripe's Identity solution now screens donor cards against sanctions lists in real time, reducing chargebacks linked to compliance flags. Meanwhile, blockchain-based service GivingBlock logged 7,400 crypto contributions for oncology campaigns last year, proving that asset-agnostic payment rails increase access for diaspora contributors and foster timely lifesaving treatment disbursements. Micro-installment features are another game changer. Razorpay's new PayLater widget allows Indian donors to split a 10,000-rupee pledge into four interest-free tranches, widening the donor pool without diluting net proceeds. For U.S. audiences, PayPal's Complete Payouts API issues same-day transfers once hospital invoices are verified, preventing costly treatment postponements. These developments signal a broader shift as the medical crowd funding market converges with embedded finance; campaigns now operate more like on-demand benefit plans than one-time charity appeals. Crucially, every transaction updates a programmable ledger, making it easier for employers or community groups to match payments in real time. Speed, transparency and optionality now reinforce donor confidence across income and age. Regional Landscape Analysis Highlighting North America, Asia-Pacific, Europe, Latin America Regional performance diverges significantly, reflecting healthcare reimbursement gaps and cultural attitudes toward community aid. In North America, the medical crowd funding market remains dominated by U.S. campaigns, which totaled about 540,000 in 2023, driven by high out-of-pocket expenses for insulin, fertility, and trauma care. Canada shows slower but steady adoption because provincial coverage softens acute financial pain; campaigns there skew toward adjunct costs like accommodation near tertiary hospitals. Mexico's regulated donor-tax deduction, introduced in 2022, is gradually stimulating formal documentation, making local platforms such as Donadora more attractive to middle-class families who previously relied on church drives, and social media influencers are amplifying verified pediatric oncology campaigns nationwide today. In Asia-Pacific, Ketto and experienced campaign surges after policy reforms allowing digital wallet KYC through Aadhaar and SingPass slashed onboarding time to minutes. Japan's Readyfor introduced hospital-coordinated group fundraising, pooling resources from 3,000 alumni networks for a single liver transplant in Osaka, illustrating collectivist dynamics. Europe, meanwhile, is shaped by GDPR-aligned privacy expectations; Leetchi's anonymized donor wall became a popular compromise, balancing transparency with data minimization. Latin America continues to wrestle with payment fragmentation; yet, Chile's Fintual integration enabled stablecoin gifting, supporting Venezuelan migrants financing dialysis in Santiago. Collectively, these trends confirm the medical crowd funding market adapts to regional regulatory, infrastructural and cultural contours rather than following blueprint. Disease Specific Campaign Dynamics Revealing Oncology, Rare Disorders, Transplant Gaps Oncology remains the most frequent driver of campaigns, but deeper examination shows widening sub-segments. Pediatric leukemia requests increasingly cite genomic sequencing costs, averaging 7,200 dollars per patient, according to St. Jude-curated data sets. In contrast, adult solid-tumor fundraisers prioritize unpaid caretaker leave, with median lost wages approaching 30,000 dollars across a six-month treatment window. Such divergent needs underscore why the medical crowd funding market cannot rely on generic messaging. Campaigns that explicitly list line-item expenses now secure first donations two days faster than narrative-only appeals, as donors value clarity. Notably, 2024 saw the first integration of Roche Foundation bridge grants directly within breast-cancer fundraising pages, enhancing continuity of drug access. Rare-disease campaigns display different stress points: enzyme-replacement therapies often exceed lifetime insurance caps, pushing families toward recurring quarterly fundraisers instead of single events. Platforms have addressed fatigue by bundling subscriptions, letting supporters authorize automatic 50-dollar renewals that reduce organizer effort. For transplant cases, attention has shifted from surgical bills to long-term immunosuppressant adherence; Lifeline Analytics recorded 12,500 post-transplant medication drives in 2023, a six-fold rise over 2019. This pivot explains why the medical crowd funding market is partnering with pharmacy benefit managers willing to preload debit cards limited to drug NDC codes. By aligning campaign disbursement with clinical protocols, organizers and donors now share measurable outcome benchmarks effectively. Donor Behavior Insights Reflecting Demographic Shifts, Motivations, Storytelling Preferences Online Demographic analytics gathered across 12 leading platforms reveal that Gen Z now accounts for 380,000 unique donors annually, overtaking Baby Boomers in volume for the first time. Their contribution sizes are smaller—averaging 28 dollars—but frequency doubles that of older cohorts due to subscription models. Emojis, vertical short-form video, and transparent fee disclosures resonate strongly, bringing click-through conversion to one in seven profile views. This influx is significant for the medical crowd funding market because younger donors show heightened interest in impact tracking; dashboards that update milestones, such as 'completed second chemotherapy cycle,' trigger repeat gifts within 48 hours. Engagement pipelines therefore require social-media literacy alongside financial acumen during uncertain economic climates. Motivational psychology studies conducted by Johns Hopkins in late 2023 show that storytelling length directly affects trust. Narratives of 300 to 400 words with at least two diagnostic documents attached produced the highest willingness to donate again within one month. Beyond wording, the inclusion of physician voice notes raised perceived authenticity scores from three to five on a Likert-style scale. Not surprisingly, platforms are embedding drag-and-drop tele-consult recordings. This adaptive presentation demonstrates how the medical crowd funding market turns user-experience research into rapid feature updates. Combined with sentiment-analysis models that alert organizers when tone drifts toward guilt-baiting, these tools maintain ethical storytelling without sacrificing urgency or donor empathy. Modify Report as Per Requirements: Future Outlook Emphasizing Ethical AI, Verification, Community Ownership, Sustainable Impact Looking forward, predictive triage engines will rank campaigns by clinical severity and funding runway, guiding donor attention toward time-critical cases without compromising organizer autonomy. Already, Israel-based startup Aidocare processes radiology reports to assign urgency scores, with pilots on two global platforms. Such algorithmic visibility will only gain traction if paired with bias audits and community oversight boards. The medical crowd funding market also anticipates broader adoption of zero-knowledge proofs, allowing beneficiaries to validate diagnoses to auditors without revealing identifiable data, thus reconciling privacy and transparency. Together, these technologies promise a future where integrity audits happen in milliseconds, freeing donors to focus on empathetic giving while curbing misinformation and duplicate appeals. Community ownership models are equally compelling. Kenya's MicroPool prototype constitutes a decentralized mutual-aid treasury where local cooperatives stake tokens redeemable for medical invoices; surplus yields replenish emergency coffers, lowering reliance on episodic appeals. Meanwhile, U.K. regulators approved the first Social Impact Bond linking donor repayments to confirmed improvements in quality-adjusted life years for cystic-fibrosis patients. By rewarding measurable outcomes, the structure nudges the medical crowd funding market toward accountable sustainability. Finally, as large language models become embedded, expect auto-generated campaign drafts that pre-check regulatory language, cite peer-reviewed studies, and calibrate tone in line with health-literacy best practices, ensuring ethical persuasion at unparalleled scale across diverse socioeconomic user bases. Global Medical Crowdfunding Market Major Players: Sartorius AG Thermo Fisher Scientific GE Healthcare Merck KGaA Eppendorf SE Pall Corporation (Danaher Corporation) Solaris Biotech Cytiva Chemtrix CerCell Infors AG Other Prominent Players Key Market Segmentation: By Crowdfunding Type Donation-based Equity-based Debt-based Reward-based By Indication Cancer Treatments Rare Diseases Organ Transplants Emergency Surgeries Mental Health Treatments Rehabilitation & Recovery Pediatric Care Others By Application Medical Treatments Research Funding Health Initiatives Medical Equipment Purchase By End User Individuals Non-Profit Organizations Healthcare Institutions By Distribution Channel Direct-to-Consumer Third-Party Platforms By Region North America Europe Asia Pacific Middle East & Africa (MEA) South America Have Questions? Reach Out Before Buying: About Astute Analytica Astute Analytica is a global market research and advisory firm providing data-driven insights across industries such as technology, healthcare, chemicals, semiconductors, FMCG, and more. We publish multiple reports daily, equipping businesses with the intelligence they need to navigate market trends, emerging opportunities, competitive landscapes, and technological advancements. With a team of experienced business analysts, economists, and industry experts, we deliver accurate, in-depth, and actionable research tailored to meet the strategic needs of our clients. At Astute Analytica, our clients come first, and we are committed to delivering cost-effective, high-value research solutions that drive success in an evolving marketplace. Contact Us:Astute AnalyticaPhone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)For Sales Enquiries: sales@ Follow us on: LinkedIn | Twitter | YouTube CONTACT: Contact Us: Astute Analytica Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) For Sales Enquiries: sales@ Website:
